Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PDE5a Inhibition Restricts Cancer Metastasis by Disrupting NPC1-Mediated Cholesterol Trafficking Through a Non-canonical cGMP-Dependent Pathway.

Cancer research·2026
Same author

Psychologically informed reminder messages for promoting BRCA1/2 carrier screening: evidence from a large-scale population-based study.

European journal of public health·2026
Same author

CUL3-Related Neurodevelopmental Disorder: Expanding the Prenatal Phenotype.

Prenatal diagnosis·2026
Same author

Does normal fetal brain imaging in monochorionic twins following co-twin fetal demise eliminate the risk of adverse neurodevelopmental outcome?

Archives of gynecology and obstetrics·2025
Same author

Second stage of labor beyond 4 h in nulliparous patients with epidural analgesia: implications and outcomes-a retrospective cohort.

Archives of gynecology and obstetrics·2025
Same author

A case of a young patient with progressive vision loss: An atypical presentation of the rare Wolfram Syndrome in a Middle Eastern individual.

American journal of ophthalmology case reports·2025

Related Experiment Video

Updated: Sep 6, 2025

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

10.4K

Large scale population screening for Duchenne muscular dystrophy-Predictable and unpredictable challenges.

Gal Cohen1,2, Atalia Shtorch-Asor3, Shay Ben-Shachar2,4

  • 1Department of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba, Israel.

Prenatal Diagnosis
|June 25, 2022
PubMed
Summary

Duchenne muscular dystrophy (DMD) carrier screening in Israel found a 1:1374 carrier rate, with most carriers lacking a family history. This highlights the value of population screening for DMD variants.

More Related Videos

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

6.9K
Assessing Functional Performance in the Mdx Mouse Model
10:32

Assessing Functional Performance in the Mdx Mouse Model

Published on: March 27, 2014

32.7K

Related Experiment Videos

Last Updated: Sep 6, 2025

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

10.4K
Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

6.9K
Assessing Functional Performance in the Mdx Mouse Model
10:32

Assessing Functional Performance in the Mdx Mouse Model

Published on: March 27, 2014

32.7K

Area of Science:

  • Genetics
  • Neuromuscular Disorders
  • Population Screening

Background:

  • Duchenne muscular dystrophy (DMD) is primarily caused by large deletions and duplications in the DMD gene.
  • A nationwide carrier screening program for DMD was established in Israel in 2020.

Purpose of the Study:

  • To determine the carrier rate and spectrum of DMD variants in a screened cohort.
  • To analyze the efficacy and challenges of population-based DMD screening.

Main Methods:

  • Multiplex ligation-dependent probe amplification (MLPA) was used for copy number analysis of all 79 DMD exons.
  • Consecutive sequencing was performed for suspected single exon deletions.

Main Results:

  • A carrier rate of 1:1374 was identified, with 7 multi-exon deletions and 4 multi-exon duplications found.
  • Nine pathogenic variants were confirmed, with only three carriers reporting a family history.
  • 81 suspected single exon deletions were re-evaluated, revealing nucleotide variants affecting probe hybridization.

Conclusions:

  • Population screening for DMD variants has a significant yield, identifying carriers often unaware of their status.
  • Screening strategies must account for methodological limitations and potential need for extensive genetic counseling.